U.S. Stock News

Why the latest equity raise matters for Essential Properties Realty Trust Essential Properties Realty Trust (EPRT) has raised approximately US$350 million through a completed follow on equity offering of 10,869,565 common shares, priced at US$32.20 with a US$1.288 discount per share. This capital raise comes shortly after the company reported its fourth quarter and full year 2025 results. It provides a current data point to consider how the new equity, reported revenue of US$561.22 million,...

Brixmor Property Group (BRX) shares are in focus after the company reported fourth quarter and full year 2025 results, issued 2026 earnings guidance, and reaffirmed its quarterly cash dividend for shareholders. See our latest analysis for Brixmor Property Group. The earnings release, fresh 2026 guidance and dividend affirmation have come alongside firm price momentum, with a 30 day share price return of 12.31% and a year to date share price return of 14.25%. The 5 year total shareholder...

SS&C Technologies Holdings (SSNC) recently confirmed a quarterly dividend of $0.27 per share and launched the ALPS Nautilus SMR, Nuclear & Technology ETF, while also completing onboarding for Australian super fund REI Super. See our latest analysis for SS&C Technologies Holdings. Despite the dividend confirmation and new ETF launch, SS&C Technologies Holdings' recent share price momentum has softened, with a 30 day share price return of a 16.33% decline and a year to date share price return...

Why Celanese is Back on Investors’ Radar Celanese (CE) has caught investor attention after recent share price swings, with the stock down around 1% on the day and roughly 8% over the past week, yet showing a gain over the past month. See our latest analysis for Celanese. For context, Celanese’s recent pullback comes after a strong run, with a 30 day share price return of 13.87% and a 90 day share price return of 39.64%, while the 1 year total shareholder return is 2.81% and longer term total...

Why Essex Property Trust (ESS) Is Back on Investors’ Radar Essex Property Trust (ESS) has drawn renewed attention after a mixed set of return figures, with a roughly flat move over the past month and a negative total return over the past year. For a large West Coast focused multifamily REIT with over 62,000 apartment homes and annual revenue of about US$1.94b, these recent return numbers give investors a fresh reason to revisit the story. See our latest analysis for Essex Property Trust. At a...

NOV (NOV) is back in focus after its Board of Directors approved a 20% increase in the regular quarterly cash dividend to $0.09 per share, which signals the company’s current capital return priorities. See our latest analysis for NOV. That dividend hike comes as NOV’s share price has climbed to $20.39, with a 7 day share price return of 6.2% and a 90 day share price return of 35.66%. This suggests momentum has been building, while the 1 year total shareholder return of 40.30% contrasts with a...

In early February, analysts at J.P. Morgan and UBS reiterated Hold ratings on Regions Financial while upgrading their outlook on the bank amid a supportive regulatory backdrop and steady sector fundamentals, even after the company’s fiscal Q4 2025 results missed estimates. At the same time, Regions’ dividend profile, including a US$0.26 per share payout and several increases over recent years, has helped underpin investor confidence despite mixed earnings. With recent analyst commentary...

If you are looking at Bitdeer Technologies Group and wondering whether the recent share price reflects a fair value, you are not alone. The stock last closed at US$7.78, after share price returns of a 22.8% decline over 7 days, a 46.5% decline over 30 days and a 32.6% decline year to date, with a 40.6% decline over the past year and a 26.9% decline over three years. Recent news coverage has focused on Bitdeer Technologies Group as a listed player in the broader software and crypto...

Recent performance snapshot MKS (MKSI) has drawn investor interest after a recent move that leaves the shares about 19% higher over the past month and roughly 73% higher in the past 3 months, based on the latest available returns. See our latest analysis for MKS. Set against a 1 year total shareholder return of 153.62% and a 3 year total shareholder return of 189.93%, the recent 19.45% 1 month share price return suggests momentum has been strong, even with a softer 7 day share price move. If...

In February 2026, Eastman Chemical Company completed a US$598.72 million fixed-rate senior unsecured notes offering due 2031, while its board affirmed a quarterly cash dividend of US$0.84 per share payable in April and confirmed completion of a multi-year US$3,155.42 million share repurchase program initiated in 2018. The company’s ability to fund itself through the bond market, maintain a long-running dividend stream, and finish a sizeable buyback highlights how its capital allocation...

Inter & Co, Inc. has already reported its full-year 2025 results, with net interest income rising to BRL 6.27 billion and net income to BRL 1.31 billion, and the board approved a cash dividend of US$0.113101823 per common share for shareholders of record as of February 22, 2026. For Brazilian Depositary Receipt holders, the company estimated a gross dividend of BRL 0.594689388 per BDR based on a BRL 5.2580 PTAX rate, underscoring how its U.S.-listed cash payout translates into local-currency...

Why OSI Systems is in focus today OSI Systems (OSIS) is back on investors' radar after its Security division reported that the Itemiser 4DX and new Itemiser 5X trace detection systems received ECAC/EU G1 approval, meeting stringent European aviation security standards. This certification confirms compliance with European Civil Aviation Conference and European Commission requirements, and ties directly to how the company competes in global aviation security and broader high security screening...

Grand Canyon Education, Inc. has reported its fourth-quarter and full-year 2025 results, showing higher quarterly net income of US$86.73 million and earnings per share growth, alongside issuing detailed 2026 guidance that outlines expected service revenue, operating margins and diluted EPS across each quarter and for the full year. At the same time, the company expanded its stock repurchase authorization to a very large US$2.55 billion program running through March 2027 and elevated...

In February 2026, Federal Realty Investment Trust reported past fourth-quarter and full-year 2025 results showing higher revenue and net income year over year, issued 2026 net income guidance of US$3.90–US$4.00 per diluted share, and its Board declared regular quarterly common and preferred cash dividends payable on April 15, 2026. An interesting wrinkle is that, despite having an authorized buyback in place, Federal Realty did not repurchase any shares in the fourth quarter of 2025,...

Why Dominion Energy’s earnings report is in focus Dominion Energy (D) heads into its February 23, 2026 earnings release with investors watching how the expected $0.66 EPS and revenue figures line up against recently reduced analyst expectations and earlier cautious trading. See our latest analysis for Dominion Energy. Dominion Energy’s recent moves capture that tension, with a 10.67% 1 month share price return and 7.08% 3 month share price return contrasting with a stronger 20.32% 1 year...

Earlier this week, Merit Medical Systems announced it will report quarterly earnings after Tuesday’s market close, following a prior quarter in which it exceeded analyst revenue expectations and delivered strong organic growth. This combination of an upcoming results release and evidence of recent operational momentum has sharpened investor focus on how effectively Merit is using its capital base despite scale disadvantages and a modest return on invested capital. Next, we’ll examine how the...

In February 2026, First Solar, Inc. entered into a new five-year senior unsecured revolving credit facility of US$1.50 billion, replacing its prior secured facility and releasing associated collateral to support working capital and general corporate purposes. The shift from secured to unsecured bank financing signals increased financial flexibility and confidence from lenders, potentially broadening First Solar’s options for funding expansion and managing trade-related cost pressures. With...

If you are wondering whether Moderna's current share price still reflects its long term potential, you are not alone. This article focuses squarely on what the stock might be worth based on different valuation lenses. Moderna's share price closed at US$49.87, with returns of 18.1% over the last 7 days, 2.4% over 30 days and 61.6% year to date, while the 1 year return is 40.4% and the 3 and 5 year returns are negative at 64.2% and 67.8% respectively. Recent headlines have continued to focus...

Why Blue Bird (BLBD) is on investors’ radar now Blue Bird (BLBD) has drawn fresh attention after recent share price moves that leave it trading around $61. This has prompted investors to reassess the school bus manufacturer’s value, growth profile, and risk-reward trade off. See our latest analysis for Blue Bird. Recent moves to around $61 come after a 23.06% 1 month share price return and a 30.45% year to date share price return, alongside a 73.89% 1 year total shareholder return. This...

On February 15, 2026, AtaiBeckley Inc. announced that experienced biopharma finance executive Michael Faerm will become Chief Financial Officer and principal financial officer on March 9, 2026, while current CFO Anne Johnson will shift to Chief Accounting Officer and remain principal accounting officer. This leadership reshuffle pairs Faerm’s capital-markets and operating background with Johnson’s continuity in accounting oversight, potentially sharpening AtaiBeckley’s financial execution as...

Dyne Therapeutics (DYN) is back in focus after highlighting five upcoming presentations at the 2026 Muscular Dystrophy Association conference and securing Orphan Drug designation in Japan for its myotonic dystrophy type 1 therapy. See our latest analysis for Dyne Therapeutics. Despite the recent regulatory and conference catalysts, Dyne Therapeutics’ short term momentum has cooled, with a 30 day share price return decline of 17.33% and a 90 day decline of 31.33%, even as the 1 year total...

Ryan Specialty Holdings (RYAN) just paired a mixed fourth quarter earnings report with an 8.3% dividend increase and a new US$300 million buyback plan, a combination that quickly drew fresh attention to the stock. See our latest analysis for Ryan Specialty Holdings. The mixed fourth quarter numbers, alongside the richer dividend and US$300 million buyback plan, come after a sharp reset in sentiment, with a 30 day share price return showing a 17.4% decline and a 1 year total shareholder return...

In February 2026, Caesars Entertainment reported fourth-quarter and full-year 2025 results showing modest revenue growth to US$2.92 billion in the quarter and US$11.49 billion for the year, but a wider net loss of US$250 million in Q4 and US$502 million for 2025 alongside an earnings miss. At the same time, Caesars highlighted strong momentum in its higher-growth digital betting operations and continued investment in property upgrades, while also rolling out its first in-house developed...

In recent years, Powell Industries has evolved from a small Houston manufacturer into a global provider of electrical systems, supported by strong demand evidenced by average backlog growth of 15.4% and annual earnings per share growth of 58.2% over the past two years. At the company’s annual meeting on February 18, 2026, shareholders reinforced governance continuity by re-electing two directors, approving executive pay, and appointing a new audit committee chair, aligning board oversight...